These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22888134)

  • 1. Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis.
    Quandt JA; Huh J; Baig M; Yao K; Ito N; Bryant M; Kawamura K; Pinilla C; McFarland HF; Martin R; Ito K
    J Immunol; 2012 Sep; 189(6):2897-908. PubMed ID: 22888134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
    Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
    J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface Layer Protein A Expressed in
    Mindur JE; Yadav SK; Ito N; Senoh M; Kato H; Dhib-Jalbut S; Ito K
    Microorganisms; 2020 Dec; 9(1):. PubMed ID: 33374217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype.
    Prat E; Tomaru U; Sabater L; Park DM; Granger R; Kruse N; Ohayon JM; Bettinotti MP; Martin R
    J Neuroimmunol; 2005 Oct; 167(1-2):108-19. PubMed ID: 16111772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
    Zhang X; Tang Y; Sujkowska D; Wang J; Ramgolam V; Sospedra M; Adams J; Martin R; Pinilla C; Markovic-Plese S
    Eur J Immunol; 2008 May; 38(5):1297-309. PubMed ID: 18412170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.
    Kaushansky N; Eisenstein M; Boura-Halfon S; Hansen BE; Nielsen CH; Milo R; Zeilig G; Lassmann H; Altmann DM; Ben-Nun A
    J Biol Chem; 2015 Jun; 290(24):15260-78. PubMed ID: 25911099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S
    Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.
    Nalawade SA; Ji N; Raphael I; Pratt A; Kraig E; Forsthuber TG
    Cell Immunol; 2018 Sep; 331():38-48. PubMed ID: 29789121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of spontaneous disease in an HLA-DR15 and TCR transgenic multiple sclerosis model.
    Ellmerich S; Mycko M; Takacs K; Waldner H; Wahid FN; Boyton RJ; King RH; Smith PA; Amor S; Herlihy AH; Hewitt RE; Jutton M; Price DA; Hafler DA; Kuchroo VK; Altmann DM
    J Immunol; 2005 Feb; 174(4):1938-46. PubMed ID: 15699121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.
    Caillier SJ; Briggs F; Cree BA; Baranzini SE; Fernandez-Viña M; Ramsay PP; Khan O; Royal W; Hauser SL; Barcellos LF; Oksenberg JR
    J Immunol; 2008 Oct; 181(8):5473-80. PubMed ID: 18832704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
    Kaushansky N; Ben-Nun A
    Front Oncol; 2014; 4():280. PubMed ID: 25360418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.
    Pette M; Fujita K; Wilkinson D; Altmann DM; Trowsdale J; Giegerich G; Hinkkanen A; Epplen JT; Kappos L; Wekerle H
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7968-72. PubMed ID: 1700423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different development of myelin basic protein agonist- and antagonist-specific human TCR transgenic T cells in the thymus and periphery.
    Kawamura K; Yao K; Shukaliak-Quandt JA; Huh J; Baig M; Quigley L; Ito N; Necker A; McFarland HF; Muraro PA; Martin R; Ito K
    J Immunol; 2008 Oct; 181(8):5462-72. PubMed ID: 18832703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires.
    Scholz EM; Marcilla M; Daura X; Arribas-Layton D; James EA; Alvarez I
    Front Immunol; 2017; 8():984. PubMed ID: 28871256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background.
    Yeola AP; Ignatius Arokia Doss PM; Baillargeon J; Akbar I; Mailhot B; Balood M; Talbot S; Anderson AC; Lacroix S; Rangachari M
    Front Immunol; 2019; 10():3115. PubMed ID: 32010149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.